Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer

AG Sowalsky, Z Xia, L Wang, H Zhao, S Chen… - Molecular Cancer …, 2015 - AACR
Men with metastatic prostate cancer who are treated with androgen deprivation therapies
(ADT) usually relapse within 2 to 3 years with disease that is termed castration-resistant …
被引用次数：201 相关文章
[PDF] psu.edu

[PDF][PDF] Whole Transcriptome Sequencing Reveals Extensive Unspliced mRNA in Metastatic Castration-Resistant Prostate Cancer

AG Sowalsky, Z Xia, L Wang, H Zhao, S Chen… - Mol Cancer Res, 2015 - Citeseer
Men with metastatic prostate cancer who are treated with androgen deprivation therapies
(ADT) usually relapse within 2 to 3 years with disease that is termed castration-resistant …

Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer.

AG Sowalsky, Z Xia, L Wang, H Zhao… - Molecular Cancer …, 2014 - europepmc.org
Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant
prostate cancer. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer

AG Sowalsky, Z Xia, L Wang, H Zhao… - Molecular cancer …, 2015 - pubmed.ncbi.nlm.nih.gov
Men with metastatic prostate cancer who are treated with androgen deprivation therapies
(ADT) usually relapse within 2 to 3 years with disease that is termed castration-resistant …

Whole Transcriptome Sequencing Reveals Extensive Unspliced mRNA in Metastatic Castration-Resistant Prostate Cancer

AG Sowalsky, Z Xia, L Wang, H Zhao, S Chen… - Molecular Cancer …, 2015 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Men with metastatic prostate cancer who are
treated with androgen deprivation therapies (ADT) usually relapse within 2 to 3 years with …
[HTML] nih.gov

[HTML][HTML] Whole Transcriptome Sequencing Reveals Extensive Unspliced mRNA in Metastatic Castration-Resistant Prostate Cancer

AG Sowalsky, Z Xia, L Wang, H Zhao… - Molecular cancer …, 2015 - ncbi.nlm.nih.gov
Men with metastatic prostate cancer (PCa) who are treated with androgen deprivation
therapies (ADT) usually relapse within 2–3 years with disease that is termed castration …

Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer

AG Sowalsky, Z Xia, L Wang… - Molecular Cancer …, 2015 - mayoclinic.elsevierpure.com
Men with metastatic prostate cancer who are treated with androgen deprivation therapies
(ADT) usually relapse within 2 to 3 years with disease that is termed castration-resistant …

Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer

AG Sowalsky, Z Xia, L Wang, H Zhao… - Molecular Cancer …, 2015 - ohsu.elsevierpure.com
Men with metastatic prostate cancer who are treated with androgen deprivation therapies
(ADT) usually relapse within 2 to 3 years with disease that is termed castration-resistant …
[PDF] psu.edu

[PDF][PDF] Whole Transcriptome Sequencing Reveals Extensive Unspliced mRNA in Metastatic Castration-Resistant Prostate Cancer

AG Sowalsky, Z Xia, L Wang, H Zhao, S Chen… - Citeseer
Men with metastatic prostate cancer who are treated with androgen deprivation therapies
(ADT) usually relapse within 2 to 3 years with disease that is termed castration-resistant …